AVANIR PHARMACEUTICALS, INC CL A
AVNR
AVNR was delisted on the 12th of January, 2015.
95 hedge funds and large institutions have $473M invested in AVANIR PHARMACEUTICALS, INC CL A in 2013 Q2 according to their latest regulatory filings, with 95 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
80% more call options, than puts
Call options by funds: $5.99M | Put options by funds: $3.33M
Top Buyers
Top Sellers
AVNR Hedge Fund Activity: Q2 2013 in Review
95 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in AVANIR PHARMACEUTICALS, INC CL A (AVNR) for Q2 2013, worth a combined $473M.
Buyers outnumbered sellers: 95 funds opened new AVNR positions and 0 closed out — a net gain of 95 holders — while 0 added to existing stakes and 0 trimmed.
- 95 institutional investors held AVANIR PHARMACEUTICALS, INC CL A (AVNR) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $473M of AVANIR PHARMACEUTICALS, INC CL A stock for Q2 2013.
- 95 funds opened new AVANIR PHARMACEUTICALS, INC CL A positions in Q2 2013 and 0 closed out, a net change of +95 holders.
Based on aggregated 13F filings for Q2 2013.